
    
      Following randomization, infants will be managed as usual practice. The treating physicians
      of the HRC-display group will be able to utilize the HRC score to assist in the care of the
      infant. The physicians of the no-display group will provide care as per standard.

      Clinical symptoms will be treated according to the medical discretion of each physician.
      Cultures will be obtained and antibiotics administered as per the medical discretion of the
      physicians.

      Clinical, culture results, antibiotic administration, ventilator use, and outcome at 120 days
      data will be collected on the infants as well as their HRC score calculated by the HeRO heart
      rate characteristics monitor.
    
  